Support programs and
resources for taking on PAH
Support programs
and resources for
taking on PAH
 
Understand who your support team is and remember that you’re never alone
Your team can consist of your healthcare team, your caregivers (like family and friends), your PAH community, your pharmacy, and your Case Manager at Actelion Pathways®.
Actelion Support
Programs
Actelion Pathways information and support for people taking UPTRAVI® (selexipag)
When you are prescribed UPTRAVI, your healthcare provider can help you enroll in Actelion Pathways. Once you are enrolled, a Case Manager will help coordinate with your healthcare provider, insurance company, and specialty pharmacy to find out if you have coverage for UPTRAVI, as well as inform you of possible financial assistance programs.
Support at Every Step
Actelion Pathways PAH Companion* provides one-on-one educational support to help you start and stay on your prescribed Actelion medication and resources to help you partner with your healthcare team to better manage your pulmonary arterial hypertension (PAH).
Look to the Actelion Pathways PAH Companion* for:
Tools to help you have more productive discussions with your healthcare team
Tips for engaging with your support network (friends, family, and peers)
Ongoing education on managing and living with PAH
Connection with a dedicated PAH Companion* through email, phone, and/or text
*Actelion Pathways PAH Companion is limited to education for patients about their Actelion therapy, its administration, and/or their disease. It is intended to supplement a patient’s understanding of their therapy, and is not intended to provide medical advice, replace a treatment plan from the patient’s doctor or nurse, provide case management services, or serve as a reason to prescribe.
As part of the program, Actelion Pathways PAH Companions* are ready to answer your questions. Patients who have enrolled can talk to a PAH Companion* by calling 1-866-300-1818, Mon-Fri, 8 AM-9 PM ET.
Print out this medical alert card to keep in your wallet, so your care team will know about your PAH in case of an emergency.
Medical Alert Wallet Card
Looking for Financial Support?
There may be options to help you pay for UPTRAVI. An Actelion Pathways Case Manager can inform you of possible financial assistance programs based on your eligibility.
1-866-ACTELION
(1-866-228-3546),
Mon-Fri, 8 AM-8 PM ET.
Before speaking to a Case Manager, have the following information available:
1
Details of your healthcare plan, including the name and contact information for the insurance company and your policy number
2
The name and contact information of your prescribing doctor (including the fax number)
Do you have
commercial
insurance?
You may be eligible for the Actelion Oral PAH Therapy Co-Pay Program. Eligible patients pay no more than $5 per UPTRAVI prescription fill through this savings program, with a 12-month maximum assistance of $20,000.
Applies to patients who have provided consent to services offered by Actelion Pathways. The Actelion Oral PAH Therapy Co-pay Program (the "Co-pay Program") is only available for residents of the US and Puerto Rico who have commercial health insurance with co-pay/co-insurance exceeding $5 per prescription fill per Actelion oral PAH therapy. You must be 18 years or older to use the Co-pay Program for yourself or a minor. PATIENTS INELIGIBLE FOR THE CO-PAY PROGRAM INCLUDE THOSE ENROLLED IN MEDICARE, MEDICAID, VA/DOD (TRICARE), THE INDIAN HEALTH SERVICE, OR ANY OTHER FEDERAL- OR STATE-FUNDED HEALTHCARE PROGRAM, OR WHERE PROHIBITED BY LAW. The Co-pay Program is not prescription drug coverage or insurance. Actelion reserves the right to terminate or modify this program at any time or without notice. Other terms and conditions apply.
Looking for More Information?
These are independent, non-profit organizations to help you through your PAH journey.
Pulmonary Hypertension Association
Scleroderma Foundation
Blue Lips Foundation
American Heart Association
American Lung Association
COVID-19 and PAH

Visit the websites below for information regarding COVID-19 and PAH that can help keep you informed through this challenging time.

If you are currently taking UPTRAVI, please speak with your healthcare provider regarding any questions you may have. If you would like to learn more about our COVID-19-related efforts, please visit https://www.jnj.com/coronavirus.

Centers for Disease Control and Prevention (CDC)

Pulmonary Hypertension Association (PHA)

PH Aware

Delaying PAH progression starts with you
Are you armed with information you need to ask your doctor about delaying PAH progression?
IMPORTANT SAFETY INFORMATION
EXPAND +
What is the most important information about UPTRAVI?
Who should not take UPTRAVI?
  • Do not take UPTRAVI if you take gemfibrozil because this medicine may affect how UPTRAVI works and cause side effects
What is UPTRAVI?

UPTRAVI® (selexipag) is a prescription medicine used to treat pulmonary arterial hypertension (PAH, WHO Group 1), which is high blood pressure in the arteries of your lungs.

UPTRAVI can help delay (slow down) the progression of your disease and lower your risk of being hospitalized for PAH.

It is not known if UPTRAVI is safe and effective in children.

What should I tell my doctor before taking UPTRAVI?

Tell your doctor if you:

  • Have liver problems
  • Have narrowing of the pulmonary veins (veins in your lungs). This is called pulmonary veno-occlusive disease (PVOD)
  • Are pregnant or plan to become pregnant. It is not known if UPTRAVI will harm your unborn baby
  • Are breastfeeding or plan to breastfeed. It is not known if UPTRAVI passes into your breast milk. You and your doctor should decide if you will take UPTRAVI or breastfeed. You should not do both
  • Have any other medical conditions
  • Are taking any other prescription or over-the-counter medicines, vitamins, or herbal supplements
What are the possible side effects of UPTRAVI?

The most common side effects are:

  • Headache
  • Diarrhea
  • Jaw pain
  • Nausea
  • Muscle pain
  • Vomiting
  • Pain in arms or legs
  • Temporary reddening of the skin (flushing)
  • Joint pain
  • Low red blood cell count
  • Less appetite than usual
  • Rash

Talk to your doctor if you have a side effect that bothers you or does not go away. These are not all the possible side effects of UPTRAVI. For more information, ask your doctor or pharmacist.

You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Keep UPTRAVI and all other medicines away from children.

What other medicines might interact with UPTRAVI?
  • UPTRAVI and other medicines may affect each other, causing side effects. Tell your doctor about all the medicines you are taking. Do not start any new medicine until you check with your doctor
How should I take UPTRAVI?
  • Take UPTRAVI exactly as your doctor tells you to take it. Usually, your doctor will have you take UPTRAVI twice a day. Taking UPTRAVI with food may help you tolerate UPTRAVI better
  • Swallow UPTRAVI tablets whole. Do not split, crush, or chew tablets
  • Tell your doctor if you have any form of liver disease. Your doctor may need to change your dose of UPTRAVI
  • UPTRAVI is measured in micrograms (mcg). Tablets come in the following strengths: 200, 400, 600, 800, 1000, 1200, 1400, and 1600 mcg
What is UPTRAVI?

UPTRAVI® (selexipag) is a prescription medicine used to treat pulmonary arterial hypertension (PAH, WHO Group 1), which is high blood pressure in the arteries of your lungs.

UPTRAVI can help delay (slow down) the progression of your disease and lower your risk of being hospitalized for PAH.

It is not known if UPTRAVI is safe and effective in children.

+
IMPORTANT SAFETY INFORMATION
What is the most important information about UPTRAVI?
+
What is UPTRAVI?

UPTRAVI® (selexipag) is a prescription medicine used to treat pulmonary arterial hypertension

IMPORTANT SAFETY INFORMATION
What is the most important information about UPTRAVI?
Who should not take UPTRAVI?
  • Do not take UPTRAVI if you take gemfibrozil because this medicine may affect how UPTRAVI works and cause side effects
What is UPTRAVI?

UPTRAVI® (selexipag) is a prescription medicine used to treat pulmonary arterial hypertension (PAH, WHO Group 1), which is high blood pressure in the arteries of your lungs.

UPTRAVI can help delay (slow down) the progression of your disease and lower your risk of being hospitalized for PAH.

It is not known if UPTRAVI is safe and effective in children.

What should I tell my doctor before taking UPTRAVI?

Tell your doctor if you:

  • Have liver problems
  • Have narrowing of the pulmonary veins (veins in your lungs). This is called pulmonary veno-occlusive disease (PVOD)
  • Are pregnant or plan to become pregnant. It is not known if UPTRAVI will harm your unborn baby
  • Are breastfeeding or plan to breastfeed. It is not known if UPTRAVI passes into your breast milk. You and your doctor should decide if you will take UPTRAVI or breastfeed. You should not do both
  • Have any other medical conditions
  • Are taking any other prescription or over-the-counter medicines, vitamins, or herbal supplements
What are the possible side effects of UPTRAVI?

The most common side effects are:

  • Headache
  • Diarrhea
  • Jaw pain
  • Nausea
  • Muscle pain
  • Vomiting
  • Pain in arms or legs
  • Temporary reddening of the skin (flushing)
  • Joint pain
  • Low red blood cell count
  • Less appetite than usual
  • Rash

Talk to your doctor if you have a side effect that bothers you or does not go away. These are not all the possible side effects of UPTRAVI. For more information, ask your doctor or pharmacist.

You may report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Keep UPTRAVI and all other medicines away from children.

What other medicines might interact with UPTRAVI?
  • UPTRAVI and other medicines may affect each other, causing side effects. Tell your doctor about all the medicines you are taking. Do not start any new medicine until you check with your doctor
How should I take UPTRAVI?
  • Take UPTRAVI exactly as your doctor tells you to take it. Usually, your doctor will have you take UPTRAVI twice a day. Taking UPTRAVI with food may help you tolerate UPTRAVI better
  • Swallow UPTRAVI tablets whole. Do not split, crush, or chew tablets
  • Tell your doctor if you have any form of liver disease. Your doctor may need to change your dose of UPTRAVI
  • UPTRAVI is measured in micrograms (mcg). Tablets come in the following strengths: 200, 400, 600, 800, 1000, 1200, 1400, and 1600 mcg
What is UPTRAVI?

UPTRAVI® (selexipag) is a prescription medicine used to treat pulmonary arterial hypertension (PAH, WHO Group 1), which is high blood pressure in the arteries of your lungs.

UPTRAVI can help delay (slow down) the progression of your disease and lower your risk of being hospitalized for PAH.

It is not known if UPTRAVI is safe and effective in children.